Arthritis Drugs Show How U.S. Drug Prices Defy Economics
Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.
The independent source for health policy research, polling, and news.
2,081-2,100 of 3,579 results
Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.
The federal agents warned store owners that importing drugs from foreign countries is illegal and that those helping “administer” such medicines could face penalties.
With the nation's opioid crisis, urine testing has become a booming business and is especially lucrative for doctors who operate their own labs, a Kaiser Health News investigation finds. And dozens of practitioners have earned "the lion’s share" of their Medicare income exclusively from urine drug screens.
Many of the gunshot survivors who suffered serious injuries face not only high deductibles and out-of-network charges but also lost wages.
Insurance has often been a tough-sell among these young people because they are often healthy and choosing a plan is complicated. A shorter enrollment and less outreach could dampen enthusiasm.
Medicare officials have been discussing a rule change that would give beneficiaries a share of the secretive fees and discounts that are negotiated for prescription drugs.
House Republicans want to repeal federal tax credits that have helped spur a boom in orphan drugs for rare diseases.
Increasingly, owners of nursing homes outsource services to companies in which they also have financial interest or control. That allows the nursing homes to claim to be in the red while owners reap hidden profits.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
U.S. District Judge Vince Chhabria said the vast majority of states have already prepared for the termination of the payments and already devised responses that give consumers better coverage.
Arizona is one of a few states that have declared the opioid epidemic a public health emergency. There's no uniformity in what that means from state to state, though, and even within Arizona, there's a wide divergence of opinion on how best to tackle the problem.
Medical debt is down across the country. In states that expanded Medicaid under the Affordable Care Act, the reduction is sharper.
Premature death, a dearth of treatments, mistreatment in emergency rooms and a woeful lack of funding are just a few of the problems confronting people with sickle cell disease.
It’s not just ideology; a lot of people don’t understand what the law does or how it works.
People hoping to get federal subsidized marketplace coverage may need to make sure their 2017 premiums are paid and that they filed all the correct documents with their 2016 taxes.
An explosive report prepared by a SynerMed executive alleges the California firm, which oversaw care for 1.2 million patients, fabricated documents and violated state and federal regulations for years. The state says it left low-income patients on Medicaid managed care in “imminent danger.”
Doctors offering this care charge a monthly fee for services that can be handled in the office. But patient advocates warn it is not insurance and offers no coverage for hospital or specialist care.
State regulators and insurers are looking into SynerMed, which medical groups depend upon to handle their finances and business operations. The groups, serving 1 million patients, fear a messy fallout.
From infections linked to the storm to trying to treat people with chronic diseases in damaged clinics, health officials on this American territory struggle to stay ahead of the needs.
Even though the Affordable Care Act has dodged another legislative bullet, it still faces challenges.
© 2026 KFF